Robbie Marcus
Stock Analyst at J.P. Morgan
(4.48)
# 1,078
Out of 5,090 analysts
548
Total ratings
52.7%
Success rate
8.7%
Average return
Main Sectors:
Stocks Rated by Robbie Marcus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BAX Baxter International | Reiterated: Hold | $26 → $25 | $23.00 | +8.70% | 25 | Oct 30, 2026 | |
| DXCM DexCom | Rated: Hold | $82 → $85 | $82.29 | +3.29% | 28 | Oct 30, 2026 | |
| MMSI Merit Medical Systems | Rated: Buy | $95 → $110 | $86.24 | +27.55% | 7 | Oct 30, 2026 | |
| SYK Stryker | Reiterated: Buy | $350 → $340 | $291.86 | +16.49% | 20 | Oct 30, 2026 | |
| BLCO Bausch + Lomb | Reiterated: Hold | $16 → $22 | $20.00 | +10.00% | 14 | Oct 29, 2026 | |
| CNMD CONMED | Reiterated: Hold | $45 → $50 | $44.29 | +12.89% | 21 | Oct 29, 2026 | |
| GEHC GE HealthCare Technologies | Reiterated: Hold | $70 → $80 | $76.57 | +4.48% | 6 | Oct 29, 2026 | |
| BSX Boston Scientific | Downgraded: Hold | $56 → $46 | $41.98 | +9.58% | 30 | Oct 28, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $118 | $106.20 | +11.11% | 20 | Oct 22, 2026 | |
| IART Integra LifeSciences Holdings | Reiterated: Sell | $17 → $14 | $12.75 | +9.80% | 22 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $450 → $475 | $432.01 | +9.95% | 21 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $96.54 | - | 28 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $71 → $58 | $59.55 | -2.60% | 21 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $95 → $117 | $94.52 | +23.78% | 18 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $45 | $59.05 | -23.79% | 6 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $17 | $10.58 | +60.68% | 2 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $190 → $188 | $197.88 | -4.99% | 14 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 → $28 | $19.91 | +40.63% | 6 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $29.69 | +1.04% | 1 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 → $6 | $4.87 | +23.20% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $275 → $152 | $149.68 | +1.55% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $54 → $60 | $68.10 | -11.89% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 | $92.01 | +14.12% | 25 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $6 | $1.41 | +325.53% | 16 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $275 → $370 | $318.95 | +16.01% | 25 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $17 | $26.58 | -36.04% | 5 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 → $7 | $6.86 | n/a | 27 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $7 | $13.33 | n/a | 8 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $51 | $61.25 | n/a | 20 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 → $14 | $12.30 | n/a | 10 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $8 | $4.43 | n/a | 7 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $80 → $85 | $237.60 | n/a | 13 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $95 | $123.37 | n/a | 14 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $65.99 | n/a | 1 | May 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $15.89 | n/a | 1 | Jun 8, 2018 |
Baxter International
Oct 30, 2026
Reiterated: Hold
Price Target: $26 → $25
Current: $23.00
Upside: +8.70%
DexCom
Oct 30, 2026
Rated: Hold
Price Target: $82 → $85
Current: $82.29
Upside: +3.29%
Merit Medical Systems
Oct 30, 2026
Rated: Buy
Price Target: $95 → $110
Current: $86.24
Upside: +27.55%
Stryker
Oct 30, 2026
Reiterated: Buy
Price Target: $350 → $340
Current: $291.86
Upside: +16.49%
Bausch + Lomb
Oct 29, 2026
Reiterated: Hold
Price Target: $16 → $22
Current: $20.00
Upside: +10.00%
CONMED
Oct 29, 2026
Reiterated: Hold
Price Target: $45 → $50
Current: $44.29
Upside: +12.89%
GE HealthCare Technologies
Oct 29, 2026
Reiterated: Hold
Price Target: $70 → $80
Current: $76.57
Upside: +4.48%
Boston Scientific
Oct 28, 2026
Downgraded: Hold
Price Target: $56 → $46
Current: $41.98
Upside: +9.58%
Abbott Laboratories
Oct 22, 2026
Reiterated: Buy
Price Target: $118
Current: $106.20
Upside: +11.11%
Integra LifeSciences Holdings
Oct 22, 2026
Reiterated: Sell
Price Target: $17 → $14
Current: $12.75
Upside: +9.80%
Oct 21, 2026
Rated: Buy
Price Target: $450 → $475
Current: $432.01
Upside: +9.95%
Oct 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $96.54
Upside: -
Sep 10, 2026
Rated: Hold
Price Target: $71 → $58
Current: $59.55
Upside: -2.60%
Aug 17, 2026
Reiterated: Hold
Price Target: $95 → $117
Current: $94.52
Upside: +23.78%
Aug 14, 2026
Reiterated: Buy
Price Target: $35 → $45
Current: $59.05
Upside: -23.79%
Aug 12, 2026
Reiterated: Buy
Price Target: $15 → $17
Current: $10.58
Upside: +60.68%
Aug 10, 2026
Reiterated: Hold
Price Target: $190 → $188
Current: $197.88
Upside: -4.99%
Aug 10, 2026
Reiterated: Hold
Price Target: $33 → $28
Current: $19.91
Upside: +40.63%
Aug 10, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $29.69
Upside: +1.04%
Aug 6, 2026
Reiterated: Sell
Price Target: $9 → $6
Current: $4.87
Upside: +23.20%
Aug 5, 2026
Downgraded: Hold
Price Target: $275 → $152
Current: $149.68
Upside: +1.55%
Aug 4, 2026
Reiterated: Hold
Price Target: $54 → $60
Current: $68.10
Upside: -11.89%
Jul 28, 2026
Reiterated: Buy
Price Target: $105
Current: $92.01
Upside: +14.12%
May 12, 2026
Reiterated: Sell
Price Target: $6
Current: $1.41
Upside: +325.53%
Dec 18, 2025
Upgraded: Buy
Price Target: $275 → $370
Current: $318.95
Upside: +16.01%
Nov 5, 2025
Reiterated: Buy
Price Target: $21 → $17
Current: $26.58
Upside: -36.04%
Aug 8, 2025
Reiterated: Sell
Price Target: $9 → $7
Current: $6.86
Upside: n/a
May 6, 2025
Reiterated: Hold
Price Target: $13 → $7
Current: $13.33
Upside: n/a
Feb 11, 2025
Reiterated: Buy
Price Target: $40 → $51
Current: $61.25
Upside: n/a
Dec 17, 2024
Initiated Coverage: Buy
Price Target: $9 → $14
Current: $12.30
Upside: n/a
May 8, 2024
Downgraded: Hold
Price Target: $15 → $8
Current: $4.43
Upside: n/a
May 6, 2021
Reiterated: Sell
Price Target: $80 → $85
Current: $237.60
Upside: n/a
Apr 12, 2021
Downgraded: Hold
Price Target: $95
Current: $123.37
Upside: n/a
May 28, 2019
Initiated Coverage: Buy
Price Target: $34
Current: $65.99
Upside: n/a
Jun 8, 2018
Upgraded: Buy
Price Target: $40
Current: $15.89
Upside: n/a